TherapeuticsMD, Inc. financial data

Symbol
TXMD on Nasdaq
Location
Boca Raton, FL
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 12 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 270% %
Debt-to-equity 42% %
Return On Equity 1% %
Return On Assets 1% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 11,574,362 shares
Common Stock, Shares, Outstanding 11,574,000 shares
Entity Public Float $13,408,634 USD -61%
Common Stock, Value, Issued $11,000 USD
Weighted Average Number of Shares Outstanding, Basic 11,574,000 shares 0.36%
Weighted Average Number of Shares Outstanding, Diluted 11,574,000 shares 0.36%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense $1,518,000 USD -4.2%
Operating Income (Loss) $2,123,000 USD 68%
Nonoperating Income (Expense) $2,133,000 USD -20%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $10,000 USD
Income Tax Expense (Benefit) $32,000 USD
Net Income (Loss) Attributable to Parent $302,000 USD
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $5,745,000 USD
Assets, Current $14,503,000 USD
Operating Lease, Right-of-Use Asset $5,515,000 USD
Intangible Assets, Net (Excluding Goodwill) $3,914,000 USD
Other Assets, Noncurrent $470,000 USD
Assets $38,671,000 USD
Accounts Payable, Current $263,000 USD
Employee-related Liabilities, Current $256,000 USD
Liabilities, Current $4,945,000 USD
Operating Lease, Liability, Noncurrent $5,411,000 USD
Other Liabilities, Noncurrent $871,000 USD
Liabilities $11,227,000 USD
Retained Earnings (Accumulated Deficit) $951,772,000 USD
Stockholders' Equity Attributable to Parent $27,444,000 USD 1.3%
Liabilities and Equity $38,671,000 USD

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 32,000,000 shares
Common Stock, Shares, Issued 11,574,000 shares
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $7,115,000 USD 41%
Operating Lease, Liability $7,175,000 USD -10%
Lessee, Operating Lease, Liability, to be Paid $8,948,000 USD -14%
Operating Lease, Liability, Current $1,072,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,551,000 USD 2.5%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,513,000 USD 2.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1,773,000 USD -27%
Lessee, Operating Lease, Liability, to be Paid, Year Three $1,590,000 USD 2.5%
Deferred Tax Assets, Operating Loss Carryforwards $167,366,000 USD 5.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four $1,630,000 USD 2.5%
Additional Paid in Capital $979,124,000 USD
Amortization of Intangible Assets $32,000 USD
Depreciation, Depletion and Amortization $180,000 USD 41%
Share-based Payment Arrangement, Expense $33,000 USD -84%